“March 8-9, 2023 Summit at the Crowne Plaza Suites, Foster City, CA”

Theme: “ADVANCING THE LEADING EDGE OF THE BIO-PHARMA SUPPLY CHAIN

A Glimpse into the Summit!

After successful conferences in Foster City, Brussels and Kigali (Rwanda), BSMA will return to Foster City for the 15th Annual Conference. The theme of the Conference is “Advancing the Leading edge of the Bio-Pharma Supply Chain”. Leaders of the industry are coming together to further industry capabilities in the critical areas of Clinical and Commercial Supply and Operations, Transportation and Logistics, Digital Transformation and overall supply chain management.

On Day 1, March 8, JOIN US as the morning will begin with three (3) workshops.  Following these workshops, the main conference opens with a scrumptious lunch at noon followed by the PLENARY SESSION.  At 6pm, be prepared to have a lot of fun at our SOCIAL NETWORKING PARTY!  There will be delicious food, wine and beer, live music, games, and of course – NETWORKING!

On Day 2, three full day panel tracks to address the problems and solutions of Clinical Trials and Commercial Product Launches, Transportation, and Digital Transportation.

BSMA will present its SCM AWARDS to the deserving companies, followed by its famous  COCKTAIL RECEPTION to end a truly memorial 2 day event!

NOTE:  this program is still in progress. 

BSMA SOCIAL PARTY AT CROWNE PLAZA SUITES BISTRO & LOUNGE

 We had such a blast last year, let’s have even more fun this year!  Don’t forget to signup for this awesome activity….lots of singing, dancing, finger food, beverages, getting to know each other better – NETWORKING!

CROWNE PLAZA SUITES

1221 Chess Drive, San Mateo, CA, CA 94404, US    (650) 431-2517

RESERVATIONS:  Discount rates for Attendees.  Rooms are limited so please make your reservations as soon as possible.  Click Here for Reservations.

DIRECTIONS

ADVANCING THE LEADING EDGE

OF THE BIO-PHARMA SUPPLY CHAIN

SUMMARY OF THE FULL TWO (2) DAYS

DAY 1

7:30 am – On-going: REGISTRATION for workshop
7:30 – 8:30 am: MEET & GREET BREAKFAST
8:30 am – 12:00 pm BSMA (3) WORKSHOPS
11:00 am – 12:30 pm On-going REGISTRATION for Summit
12:30 pm -2:00 pm NETWORKING LUNCH & Welcome Address
2:00 pm – 5:30 pm PLENARY SESSION
5:30pm-7:00pm NETWORKING
7:00 pm – 10:00 pm SOCIAL PARTY 

DAY 2

7:30 am – 8:30 am – On-going REGISTRATION
7:30 am – 8:30 am – MEET & GREET NETWORKING BREAKFAST
8:30 am – 5:00 pm – 3 Track Sessions:  Clinical Supply Chain, Transportation & Logistics, & Digital Transformation
5:00 pm – 6:00 pm COCKTAIL RECEPTION & AWARDS CEREMONY

DAY

ONE

REGISTRATION 

BREAKFAST – MEET & GREET

BSMA HALF-DAY WORKSHOPS

1 – “Optimizing Your Clinical Drug Forecast and Supplies Using IRT”
Join us for this half-day, interactive workshop where we will go into details and best practices on how you can utilize your IRT functionality to improve your clinical trials supply management.  This session will include an overview of the various reports and information to extract from IRT and how they can be used to make better informed decisions about your demand & supply plan.  We will also review important IRT settings for creating the user specifications, how they impact your demand & supply plan, and common pitfalls and ways to solve them in supply forecasting.  Time will be set aside to address your questions and to learn how others are taking full advantage of IRT’s powerful capabilities.
Presenter:  Catherine Hall, VP of Data and Quality, Endpoint Clinical

2 – “Introduction to the Global Supply Chain Workshop: Operations, Logistics and Compliance
Participants will be engaged in a 3-hour introduction with a seasoned global trade veteran discussing the key issues involved with the global supply chain.
Key capabilities and challenges in international trade, freight, logistics, operations and compliance will all be discussed, with a focus on pharma products.
For those considering import and export sales for the first time, this session offers a broad scan of what and how to address trade compliance; for seasoned importers and exporters this session will be a thorough compliance cross-check.
Presenter: Thomas Cook, Managing Director, Blue Tiger International

3 – “Using data and analytics to augmeugment your people and fuel your digital journey.
This interactive workshop is for individuals and organizations at any level of analytics and digital maturity. Packed with practical examples, this workshop will help organizations navigate the terrain of multiple sources/versions of the truth and get more value from their analytics initiatives by identifying and overcoming three major impediments.”
Presenter:  Randy V Bradley, PhD, CPHIMS, FHIMSS and EVP, Digital Transformation in Life Sciences, BSMA

REGULAR SUMMIT REGISTRATION

LUNCHEON

PLENARY SESSION

SCM 360◦: TAPPING INTO THE INTRINSIC POWER OF SUPPLY CHAIN MANAGEMENT FOR BREAKTHROUGHS (PANEL DISCUSSION)
Supply Chain Management executives of Biotech companies will identify the disruptions caused by the pandemic in the delivery of patient care and the changes made to maximize quality, timeliness and integrity of service delivered. Resolution(s) of the problems required rewiring of the inbound supply side as well as of the outbound delivery to a patient. Insights will be provided about traditional assumptions being challenged and transformations made in people, processes and technology to achieve a renewed objective of the enterprise.
PANEL
Stuart Poll, Vice President, Supply Chain, Illumina
Kalid Shah, PhD, Senior Vice President, Pharmaceutical and Biologics Operations, Manufacturing and Supply Chain, Exelixis
Chris Bogart, Vice President, Supply Chain Management, Bayer Pharmaceuticals
Heather Erickson, Vice President, Supply Chain Management & Business Operations, Sangamo
Paul Seaback, Chief Technical Officer, Dermavant Sciences
Moderator: Devendra Mishra, Executive Director, BSMA 

KEYNOTE: SUPPLY CHAIN MANAGEMENT – THE NEW REALITY FOR INTITUTIONAL EMPOWERMENT!
Supply chain has become a household word since the COVID-19 pandemic. During this period, companies have made a rigorous assessment of their supply chain. A story will be told how broken links were identified and a holistic approach was taken to transform the way of doing business and serving the patients.
(TBA)

DOMESTIC TRANSPORTATION ECONOMIC REVIEW – THE BLOOMBERG REPORT 
The US Transportation Network is a major nexus for the economy. This session will provide a State of The Union of each mode of transportation in the post-COVID-19 marketplace. Considering that supply chain is not properly understood but remains prevalent in our vocabulary, analysis will be made of the trials and tribulations in customer healthcare delivery. Insights will be shared of the impact of international carriers.
SPEAKER: Lee Klaskow, Sector Head and Senior Analyst, Bloomberg

FRIENDS SOURCING: AN ANTIDOTE FROM THE COVID-19 PANDEMIC WORLD                                                                  
The Biden administration warned: “The United States cannot make, mine, or manufacture everything ourselves. We must cooperate with our allies and partners to foster and promote collective supply chain resilience.” An ill-conceived implementation of this friend-shoring strategy could result in price hikes and a stronger China over time. The presentation will address US Treasury secretary Janet Yellen’s proposal to move towards friendshoring, or allyshoring – manufacturing and sourcing components and raw materials within a group of countries with shared values. “Favouring the friendshoring of supply chains to trusted countries, so we can continue to securely extend market access, will lower the risks to our economy as well as to our trusted trade partners”.
(TBA)

HOW DOES ENOUGH MEDICINE GET DELIVERED TO EVERY PATIENT?                                   
Insights will be provided of the missionary endeavor to make the U.S. a country where every human being has access to the essential medicines necessary to sustain life and conquer disease, and to reliably supply affordable, high-quality, essential medicines through U.S.-based advanced manufacturing processes.
SPEAKER: Dr. Modestus Obochi, EVP, Strategy & Business Development, Phlow

BSMA AFRICA CELEBRATES LEARNING, SHARING & NETWORKING IN KIGALI, RWANDA OCT. 31-NOV.1, 2022
Highlights of the 1st Edition of the Summit will be presented to demonstrate the alignment of AUD-NEPAD’s Pharmaceutical Manufacturing Plan of the African Union; Consortium of all the major vaccine and drug manufacturers for Local Manufacturing; MOONSHOT collaboration among countries for supply chain development; Collaboration between medical research institutions and their suppliers; Transportation Network & Cold Chain facilitation; and, the THINK TANK – Supply Chain Management Africa (SCMA. Bio-Pharma companies in the USA will have an opportunity to learn to serve the emerging market or expand their presence.
SPEAKERS
Devendra Mishra, Executive Director, BSMA
Franck Toussaint, Managing Director, BSMA Europe
Randy Bradley, Associate Professor of Information Systems and Supply Chain Management, University of Tennessee Haslam College of Business
International Healthcare Agencies
STATE OF THE UNION OF CELL & GENE THERAPY SUPPLY CHAIN                                                
What have been the unique challenges of the gene and cell therapy manufacturing processes? It has been like the Wild West. Why supply chain needs a lot of attention, from starting materials, vector banking, frozen vial to chain of custody and how to build it robustly. How does cell and gene therapy capacity planning compare to products in the past? Re-thinking the capacity dilemma: CDMO, build our own facilities or partnership strategies for facility build, space sharing, and co-control? Cryogenic storage and cold chain distribution with accountability have been Draconian demands.
(TBA)
THE NEW WORKPLACE RENAISSANCE: THE PANDEMIC PARADIGM SHIFT                                                                                    
The Pandemic has produced a Tectonic shift in the employer, employee, work and family relationship where virtual communication technologies and organizational/personal adaptability came to the rescue. The outcome was greater productivity and creativity achieved while the mental and social dimensions were impacted beyond comprehension, much of it remaining to be understood. The research will analyze the current situation and how the workplace is likely to evolve in the future.
(TBA)

THE INDUSTRY PLATFORM TO INTEGRATE DRUG DEVELOPERS WITH CRO, CMO, AND CDMO. 
Learn how enabling the collaboration of personnel and integration of organizations and information in the ecosystem for drug development can reduce time to market, lower cost of development and improve launch times.
Panelists: 
Paul Seaback, Vice President, Chief Technical Officer, Dermavant Sciences
Arvind Singh, Executive Director, Global SCM, SK Pharmteco
Mike Ragone, Sr. Director Supply Chain, Vir Biotechnology
Aparna Seksaria, Global Practice Lead R&D Solutions, SAP
Mike Dallman, Director Clinical Supply Chain, Avidity BioScience
Moderator:  Matt Blume, Vice President Business Transformation, Catalent Pharma Solutions

INTRODUCTION TO BSMA ENTERAKT
The EnterAkt platform simplifies collaboration for members of a team/group and other functional areas.  This team-based platform enables communication via conversation streams, private messaging (passed through email or SMS/text), and video within a single environment. 
Bill Coakley and Randy Bradley, BSMA

SOCIAL EXTRAVAGANZA

DAY

TWO

TRACK 1

CLINICAL  

Chairman:

Bill Coakley

EVP of Clinical & Commercial Supply Chain Mgmt

TRACK 2

TRANSPOR-TATION 

Chairman: 

Jeff Tucker

EVP of Transportation & Logistics Steering Committee

TRACK 3

   DIGITAL  

Chairman:  

Randy Bradley

EVP Digital Transforma-tion in Life Sciences

On-going REGISTRATION

MEET AND GREET BREAKFAST

TRACK 1: ADVANCING THE PEOPLE, PROCESSES & TECHNOLOGIES OF CLINICAL TRIALS

Chairman:  Bill Coakley, Executive Vice President of Clinical & Commercial Supply Chain Mgmt

OPENING REMARKS:  CLINICAL AND COMMERCIAL SUPPLY CHAIN
Bill Coakley

SUPPLY PLANNING STRATEGIES FOR CLINICAL TRIALS
Supply planning for clinical trials is challenging from a strategic perspective because of the trade-offs involved with ensuring service levels while minimizing spend. As companies increasingly focus on the cost side of this equation, finding the optimal approach to supply planning is especially important to find the optimal balance between building inventory and reducing waste at the end of the trial. Attend this session to learn about supply planning strategies and how to incorporate them into your supply chain
PANELISTS:
Ryan Mills, Sr. Director Supply Chain, Denali Therapeutics
Scott Sabalvaro, Associate Director Supply Chain, Pliant Therapeutics
Brad Graves, Sr. Manager, Development Supply Chain, Amgen
Moderator:  Sebastien Coppe, PhD, Life Science Vice President, N-Side

ERP FOR PHARMA SUPPLY CHAIN or NOT?
Proponents for and against the need for ERP for supporting Clinical and Commercial Supply Chain engage in a healthy debate.
PANELISTS:  
Ryan Pedroni, Sr Director, Operational Excellence, Eikon Therapeutics
Charles Enriquez, Sr. Director, Supply Chain Business Owner, Allogene
Cat Hall, VP of Quality and Data, Endpoint Clinical
Rutesh Desai, Sr Manager, Global Supply Chain, Beigene
Moderator:  Dan Silva, Partner, Clarkston Consulting

FIRESIDE CHAT:  A COMPANY’S JOURNEY TO ENHANCE PROCESSING AND TECHNOLOGY FOR CUTTING EDGE HEALTHCARE
The development and commercialization of four drugs over a decade has been an enormously successful journey for Exelixis, a genome-based drug discovery company. Human capital and financial Investment in process and technology have driven transformation across the enterprise from clinical and commercial operations to marketing, HR and other functions. The Digital Technology Initiative, a need-based-driven strategy, is delivering organizational agility for optimum patient across multi functions which rely totally on outsourcing of its manufacturing. Insights from the chat will pertain to the life sciences industry from start up to mature BioPharma companies.
Khalid Shah, PhD, Sr. Vice President, Exelixis and Aparna Seksaria, Global Practice Lead R&D Solutions, SAP
HOW TO APPLY ANALYTICS TO ACHIEVE A SUCCESSFUL CLINICAL STUDY
 PANELISTS:
Hilary Ross, Group Leader – Inventory Management Group, Almac Group
Catherine Hall, VP of Data and Quality, Endpoint Clinical
Donna Lucero, Manager Clinical Systems (IRT), Amgen
Moderator:  Allen Jacques, Industry Thought Leader, Kinaxis
EVOLVING THE CLINICAL SUPPLY CHAIN AHEAD OF A COMMERCIAL LAUNCH
Emerging life sciences organizations face several important decisions ahead of a potential commercial launch.  You understand the science and are deeply invested in the key milestones for your clinical trials and regulatory filings. But then what?  What organizational shifts, processes and technology that will be needed, both short and long term, to support a commercial operation?  Our panel today explores the gaps that exist between current and future capability, and the considerations surrounding people, process and technology that are necessary to bridge this gap. 
PANELISTS:  TBD
Bob Lamont, Partner at Clarkston Consulting

HOW TO ASSESS AND SELECT CLINICAL DISTRIBUTORS AND DEPOTS 
Establishing the optimum supply chain for global clinical trials, which entails the network of distribution centers, depots. packaging and labeling facilities, technology for monitoring progress, and direct to patient delivery services, is a vital contributor to the cost, efficacy and timeliness of the study. The practitioners will enumerate and analyze the operational considerations, country-specific compliance requirements, reverse logistics, capabilities of the region and trial study design. Realize that 59% of drugs and supplies for clinical trials are wasted, the panel will address how the challenge can be met.
PANELISTS: 
Brian Avison, Director of Operations, Site Lead, Catalent Clinical Development & Supply
ALMAC, TBD
Fisher, TBD
Moderator: TBD

PLENARY KEYNOTE ADDRESS

SUPPLY CHAIN MANAGEMENT EXCELLENCE AWARDS

COCKTAIL RECEPTION

WRAP UP

TRACK 2: TRANSPORTATION & LOGISTICS: NAVIGATING THE STORM

Chairman:  Jeff Tucker, Executive Vice President, Transportation & Logistics

PANEL: DIGITALIZATION

This discussion will review where digitalization is making an impact in various places, from air, to truck, to production, serialization and more. This immersive session will offer attendees an opportunity to operate more like a think tank to bring clarity to the meaning of digital transformation and chart a path of digitalization and digital transformation in life sciences.
PANELISTS: 
Stefan Braun, Managing Director, SmartCAE
Jenifer Smith, Senior Logistics Specialist, Direct Relief
Cargosense (Representatative TBD)
Andrew Setikas, Global Head of Healthcare and Life Sciences, Teradata
Moderator: Jeff Perata, Director, Pharmaceutical and Biologics Operations, Gilead

PANEL: TALENT ACQUISITION
The job market remains tight, even with inflation and a sagging global economy. How are companies working to address the talent gaps and skill deficits? What are students looking for upon graduation?
PANELISTS: 
Leon Trevett, Senior Director Global Supply Chain Planning, llumina  
Randy Bradley, Associate Professor of Information Systems and Supply Chain Management, University of Tennessee 
Larry Davis, PharmD, Professor of Practice in Clinical and Regulatory Affairs, Keck Graduate Institute
Terry Esper, PhD, Associate Professor of Logistics, The Ohio State University Fisher College of Business
Yasmeen Shoubah, Associate Packaging Engineer, Gilead Sciences

Moderator: TBD

PANEL: FINAL MILE
As medicine and therapies move from mass-production to patient-level personalized customization, the logistics solutions are changing just as rapidly. Smaller shipments, protected from temperature excursions, and entirely new solutions are necessary. Hear the latest in Final Mile.
PANELISTS:
Derek Glover, Sr. Manager Global Logistics, Novavax
Jennifer Haigh, Head of Specialty Products- Americas, United Cargo
Moderator:  Dave Malenfant, EVP Advocate In Chief, Supply Chain Management & Talent Development; Co-Chair of the UII Committee

PANEL: APPROACHES TO TRANSPORTATION-RELATED SUSTAINABILITY
After three years of massive disruptions within freight transportation, sustainability efforts are regaining prominence. This session will review achievable “wins” that move organizations in the right direction toward a sustainable future. Session will discuss: EVs (electric vehicles), Sustainable Aviation Fuels (SAF) and Biofuels and modal shifts that hit the mark.
PANELISTS:
Bill Kascel, SVP, Sustainability, Kuehne-Nagel
Ian Moriarty, VP of Sales, AeroSafe Global
Keenan Guenzel, Logistics Project Lead, Bayer
Moderator: TBD

PANEL: TRANSPORT MARKET CONDITIONS & TRENDS IN COLD CHAIN
Hear directly from executives from various transport modes and service providers, where the industry is, from a variety of standpoints. This session will build upon Day 1’s keynote session and will be expertly moderated by Bloomberg’s Lee Klaskow. Discussion will review the nature and condition of capacity in 2023 and beyond. Talk will include a “playbook” for potential recessionary environment, and what manufacturers might consider as they continue to refine strategies.
PANELISTS:
Andrew Boyle, Boyle Transportation
Other Panelists: TBD
Moderator:  Lee Klaskow, Sector Head and Senior Analyst, Bloomberg

PANEL: PACKAGING’S METAMORPHOSIS
New technologies, from refrigeration to insulation to digitalization are pouring into the cold chain industry. This session will review the latest technology available within packaging providers for the pharma and bio-pharma manufacturers, including sustainability, technology, digitalization and of course, temperature protection.
PANELISTS:
Passive- Michael Haley, Business Development Director, SkyCell AG
Digital Twin- Stefan Braun, Managing Director, SmartCAE
Moderator: TBD

INITIATIVES OF THE PHARMA AND BIO-PHARMA MANUFACTURERS
The challenges of drug manufacturers in the critical area of transportation will be discussed pertaining to cold chain services, visibility in the supply chain, sustainability of the environment in terms of carbon footprint, custom and export handling, and opportunities for greater agility and resilience.
PANELISTS:
Jeff Perata, DPBO Logistics, Gilead Sciences
Wahiba Hall, Head Supply Chain Compliance CoE, Divisional PH – Global Export Control Officer, Bayer
Moderator: Devendra Mishra, Executive Director, BSMA

PLENARY KEYNOTE ADDRESS

SUPPLY CHAIN MANAGEMENT EXCELLENCE AWARDS

COCKTAIL RECEPTION

WRAP UP

TRACK 3: DIGITAL TRANSFORMATION IN LIFE SCIENCES: CASE STUDIES

Chairman:  Randy Bradley, Executive Vice President, Digital Transformation

SESSIONS INCLUDE THE FOLLOWING TOPICS:

  • The Digital Supply Chain Journey of a Major Drug Manufacturer
  • Emerging Technologies and Lagging Processes: Examples of Breakthroughs and Lingering Opportunities
  • Digital Parallels from Leading Industries: Leading and Emerging Practices that Can Benefit Life Science

OPENING REMARKS:  DIGITALIZATION AND DIGITAL TRANSFORMATION IN LIFE SCIENCES
Randy V. Bradley, PhD, CPHIMS, FHIMSS

NOTE:  THE TALENT ACQUISITION AND DIGITALIZATION PANELS WILL BE A JOINT SESSION WITH THE TRANSPORTATION TRACK.

PANEL: TALENT ACQUISITION
The job market remains tight, even with inflation and a sagging global economy. How are companies working to address the talent gaps and skill deficits? What are students looking for upon graduation? What steps are companies taking to reskill and upskill their existing workforce? These and many other topics will be explored in this interactive discussion.
PANELISTS;
Randy V. Bradley, Associate Professor of Supply Chain and Information Systems Management, University of Tennessee
Leon Trevett, Senior Director Global Supply Chain Planning, illumina
Dr. Larry Davis, Professor of Practice in Clinical and Regulatory Affairs, Keck Graduate Institute
Terry Esper, PhD, Associate Professor of Logistics, The Ohio State University Fisher College of Business
Yasmeen Shoubah, Associate Packaging Engineer, Gilead Sciences
Moderator: TBD

PANEL: DIGITALIZATION
New technologies, from refrigeration to insulation to digitalization are pouring into the cold chain industry. This session will review the latest technology available within packaging providers for the pharma and bio-pharma manufacturers, technology, digitalization, and temperature protection.
PANELISTS:
Jenifer Smith, Senior Logistics Specialist, Direct Relief
CargoSense
Stefan Braun, Managing Director, SmartCAE
Andrew Setikas, Global Head of Healthcare and Life Sciences, Teradata
Moderator: Jeff Perata, Director, Pharmaceutical and Biologics Operations, Gilead Sciences

ROUNDTABLE GROUP DISCUSSIONS:  “WHAT IS DIGITAL TRANSFORMATION AND WHERE DO WE GO FROM HERE?”
This immersive session will offer attendees an opportunity to operate more like a think tank to bring clarity to the meaning of digital transformation and chart a path to digitalization and digital transformation in life sciences.
PANELISTS:
All digitalization track attendees

FIRESIDE CHAT/PANEL:  CHALLENGES AND APPROACHES TO DIGITALIZATION IN LIFE SCIENCES

EFFICIENCY GAINS THROUGH AUTOMATION:  THE AVOIDING PITFALLS WHEN INTRODUCING NEW SOLUTIONS
PANELISTS:
Leon Trevett, Sr. Director Global Supply Chain Planning, illumina 
Rajeev Mishra, Industry Partner – Healthcare and Life Sciences, Slalom
PREPARING FOR CHANGES BROUGHT ABOUT BY PERSONALIZED MEDICINE
Paul Brody, Americas Technology Sector Strategy Leader, EY
DIGITAL IN RETAIL:  PARALLELS WITH LIFE SCIENCES
Guy Courtin, VP Industry and Advanced Technology, Tecsys
HOW ARE COMPANIES WORKING TO ADDRESS THE TALENT GAPS AND SKILL DEFICITS
PANELISTS:
Leon Trevett, Sr. Director Global Supply Chain Planning, illumina

PLENARY KEYNOTE ADDRESS

SUPPLY CHAIN MANAGEMENT EXCELLENCE AWARDS

COCKTAIL RECEPTION

WRAP UP

BSMA Summit Parade of Sponsors

[IN PROGRESS – SOON TO BE UPDATED]

Our first group of sponsors!

Join this distinguished group of service providers!

Pin It on Pinterest

Share This